Free Trial

Entrada Therapeutics (TRDA) Insider Trading & Ownership

$15.13
+0.11 (+0.73%)
(As of 05/24/2024 ET)

Entrada Therapeutics (NASDAQ:TRDA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.58%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$151,226.80
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$1.44 M
Get TRDA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Entrada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TRDA Insider Buying and Selling by Quarter

Entrada Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/20/2024Natarajan SethuramanInsiderSell9,675$15.19$146,963.25  
5/16/2024Dipal DoshiCEOSell1,800$15.00$27,000.00  
5/16/2024Natarajan SethuramanInsiderSell1,000$15.00$15,000.00  
5/8/2024Peter S KimDirectorBuy2,276$14.04$31,955.04  
4/8/2024Peter S KimDirectorBuy2,600$13.57$35,282.00  
3/28/2024Peter S KimDirectorBuy1,512$13.75$20,790.00  
3/25/2024Peter S KimDirectorBuy3,180$13.36$42,484.80  
3/21/2024Peter S KimDirectorBuy704$13.24$9,320.96  
3/19/2024Peter S KimDirectorBuy900$12.66$11,394.00  
2/15/2024Dipal DoshiCEOSell1,000$15.00$15,000.00  
1/16/2024Dipal DoshiCEOSell1,000$15.99$15,990.00  
12/26/2023Kory James WentworthCFOSell94$16.67$1,566.98  
12/22/2023Kory James WentworthCFOSell10,206$15.69$160,132.14  
12/20/2023Dipal DoshiCEOSell1,000$15.00$15,000.00  
11/13/2023Dipal DoshiCEOSell1,000$16.23$16,230.00  
10/17/2023Dipal DoshiCEOSell1,000$15.00$15,000.00  
9/13/2023Dipal DoshiCEOSell1,000$15.00$15,000.00  
9/6/2023Kory James WentworthCFOSell950$13.48$12,806.00  
9/6/2023Nathan J DowdenCOOSell972$13.47$13,092.84  
9/6/2023Nerissa KreherInsiderSell892$13.48$12,024.16  
8/14/2023Dipal DoshiCEOSell1,000$15.67$15,670.00  
8/4/2023Nerissa KreherInsiderSell6,898$14.14$97,537.72  
8/2/2023Nerissa KreherInsiderSell10,348$15.19$157,186.12  
7/11/2023Kory James WentworthCFOSell3,884$18.00$69,912.00  
7/10/2023Natarajan SethuramanInsiderSell3,026$18.00$54,468.00  
7/10/2023Nathan J DowdenCOOSell3,200$18.00$57,600.00  
6/22/2023Nathan J DowdenCOOSell7,097$16.02$113,693.94  
6/21/2023Kory James WentworthCFOSell17,500$15.01$262,675.00  
6/20/2023Nathan J DowdenCOOSell8,885$14.94$132,741.90  
(Data available from 1/1/2013 forward)

TRDA Insider Trading Activity - Frequently Asked Questions

Who is on Entrada Therapeutics's Insider Roster?

The list of insiders at Entrada Therapeutics includes Bros. Advisors Lp Baker, Dipal Doshi, John F Crowley, Kory James Wentworth, Natarajan Sethuraman, Nathan J Dowden, Nerissa Kreher, and Peter S Kim. Learn more on insiders at TRDA.

What percentage of Entrada Therapeutics stock is owned by insiders?

7.58% of Entrada Therapeutics stock is owned by insiders. Learn more on TRDA's insider holdings.

Which Entrada Therapeutics insiders have been buying company stock?

The following insiders have purchased TRDA shares in the last 24 months: Bros. Advisors Lp Baker ($260,910.90), and Peter S Kim ($151,226.80).

How much insider buying is happening at Entrada Therapeutics?

Insiders have purchased a total of 52,119 TRDA shares in the last 24 months for a total of $412,137.70 bought.

Which Entrada Therapeutics insiders have been selling company stock?

The following insiders have sold TRDA shares in the last 24 months: Dipal Doshi ($847,721.49), Kory James Wentworth ($715,158.61), Natarajan Sethuraman ($287,729.25), Nathan J Dowden ($634,730.84), and Nerissa Kreher ($607,464.99).

How much insider selling is happening at Entrada Therapeutics?

Insiders have sold a total of 196,723 Entrada Therapeutics shares in the last 24 months for a total of $3,092,805.18 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:TRDA) was last updated on 5/26/2024 by MarketBeat.com Staff

From Our Partners